K G Friedman1,2, L A Sleeper1,2, L R Freud1,2, A C Marshall1,2, M E Godfrey1,2, M Drogosz1, T Lafranchi1, C B Benson3,4, L E Wilkins-Haug3,4, W Tworetzky1,2. 1. Department of Cardiology, Boston Children's Hospital, Boston, MA, USA. 2. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. 3. Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA. 4. Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA, USA.
Abstract
OBJECTIVES: Fetal aortic valvuloplasty (FAV) may prevent progression of mid-gestation aortic stenosis to hypoplastic left heart syndrome (HLHS). The aim of this study was to evaluate whether technical success and biventricular (Biv) outcome after FAV have changed from an earlier (2000-2008) to a more recent (2009-2015) era and identify pre-FAV predictors of Biv outcome. METHODS: We evaluated procedural and postnatal outcomes in 123 fetuses that underwent FAV for evolving HLHS at Boston Children's Hospital between 2000 and 2015. The primary outcome measure was circulation type (Biv vs single ventricle) at the time of neonatal hospital discharge. Classification and regression tree (CART) analysis was performed to construct a stratification algorithm to predict Biv circulation based on pre-FAV fetal variables. RESULTS: The FAV procedure was technically successful in 101/123 (82%) fetuses, with a higher technical success rate in the more recent era than in the earlier one (49/52 (94%) vs 52/71 (73%); P = 0.003). In liveborn patients, the incidence of Biv outcome was higher in the recent than in the earlier era, both in the entire liveborn cohort (29/49 (59%) vs 16/62 (26%); P = 0.001) and in those in whom the procedure was technically successful (27/46 (59%) vs 15/47 (32%); P = 0.007). Independent predictors of Biv outcome were higher left ventricular (LV) pressure, larger ascending aorta, better LV diastolic function and higher LV long-axis Z-score. On CART analysis, fetuses with LV pressure > 47 mmHg and ascending aorta Z-score ≥ 0.57 had a 92% probability of Biv outcome (n = 24). Those with a lower LV pressure, or mitral dimension Z-score < 0.1 and mitral valve inflow time Z-score < -2 (n = 34) were unlikely to have Biv (probability of 9%). The remainder of the patients had an intermediate (∼40-60%) likelihood of Biv circulation. CONCLUSIONS: The proportion of patients achieving Biv outcome after FAV has increased, probably owing to an improved technical success rate and modified selection criteria. Fetal factors, including LV pressure, size of the ascending aorta and diastolic function, are associated with likelihood of Biv circulation after FAV.
OBJECTIVES:Fetal aortic valvuloplasty (FAV) may prevent progression of mid-gestation aortic stenosis to hypoplastic left heart syndrome (HLHS). The aim of this study was to evaluate whether technical success and biventricular (Biv) outcome after FAV have changed from an earlier (2000-2008) to a more recent (2009-2015) era and identify pre-FAV predictors of Biv outcome. METHODS: We evaluated procedural and postnatal outcomes in 123 fetuses that underwent FAV for evolving HLHS at Boston Children's Hospital between 2000 and 2015. The primary outcome measure was circulation type (Biv vs single ventricle) at the time of neonatal hospital discharge. Classification and regression tree (CART) analysis was performed to construct a stratification algorithm to predict Biv circulation based on pre-FAV fetal variables. RESULTS: The FAV procedure was technically successful in 101/123 (82%) fetuses, with a higher technical success rate in the more recent era than in the earlier one (49/52 (94%) vs 52/71 (73%); P = 0.003). In liveborn patients, the incidence of Biv outcome was higher in the recent than in the earlier era, both in the entire liveborn cohort (29/49 (59%) vs 16/62 (26%); P = 0.001) and in those in whom the procedure was technically successful (27/46 (59%) vs 15/47 (32%); P = 0.007). Independent predictors of Biv outcome were higher left ventricular (LV) pressure, larger ascending aorta, better LV diastolic function and higher LV long-axis Z-score. On CART analysis, fetuses with LV pressure > 47 mmHg and ascending aorta Z-score ≥ 0.57 had a 92% probability of Biv outcome (n = 24). Those with a lower LV pressure, or mitral dimension Z-score < 0.1 and mitral valve inflow time Z-score < -2 (n = 34) were unlikely to have Biv (probability of 9%). The remainder of the patients had an intermediate (∼40-60%) likelihood of Biv circulation. CONCLUSIONS: The proportion of patients achieving Biv outcome after FAV has increased, probably owing to an improved technical success rate and modified selection criteria. Fetal factors, including LV pressure, size of the ascending aorta and diastolic function, are associated with likelihood of Biv circulation after FAV.
Authors: Sarah S Pickard; John B Wong; Emily M Bucholz; Jane W Newburger; Wayne Tworetzky; Terra Lafranchi; Carol B Benson; Louise E Wilkins-Haug; Diego Porras; Ryan Callahan; Kevin G Friedman Journal: Circ Cardiovasc Qual Outcomes Date: 2020-04-07
Authors: Merna Atiyah; Ahmed Kurdi; Osama Al Tuwaijry; Atif Al Sahari; Maha Al Rakaf; Inas Babic; Fahad Al Habshan; Zohair Alhalees; Khalid Al Najashi Journal: J Cardiothorac Surg Date: 2020-06-22 Impact factor: 1.637
Authors: Chi Wei Ong; Meifeng Ren; Hadi Wiputra; Joy Mojumder; Wei Xuan Chan; Andreas Tulzer; Gerald Tulzer; Martin Lindsay Buist; Citra Nurfarah Zaini Mattar; Lik Chuan Lee; Choon Hwai Yap Journal: Ann Biomed Eng Date: 2020-11-11 Impact factor: 3.934
Authors: A Tulzer; W Arzt; R Gitter; E Sames-Dolzer; M Kreuzer; R Mair; G Tulzer Journal: Ultrasound Obstet Gynecol Date: 2022-04-11 Impact factor: 8.678
Authors: Andreas Tulzer; James C Huhta; Julian Hochpoechler; Kathrin Holzer; Thomas Karas; David Kielmayer; Gerald Tulzer Journal: Front Pediatr Date: 2022-07-08 Impact factor: 3.569